0000883984-24-000007.txt : 20240229 0000883984-24-000007.hdr.sgml : 20240229 20240229083234 ACCESSION NUMBER: 0000883984-24-000007 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240228 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240229 DATE AS OF CHANGE: 20240229 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 24699106 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 8-K 1 icui-20240228.htm 8-K icui-20240228
falseICU MEDICAL INC/DE000088398400008839842024-02-282024-02-28

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 FORM 8-K

CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) 02/28/2024

ICU MEDICAL, INC.

(Exact name of registrant as specified in its charter)
Delaware001-3463433-0022692
(State or other jurisdiction
of incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
951 Calle Amanecer,San Clemente,California92673
(Address of principal executive offices)(Zip Code)

(949) 366-2183
Registrant's telephone number, including area code

N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading SymbolName of each exchange on which registered
Common stock, par value $0.10 per shareICUIThe Nasdaq Stock Market LLC
(Global Select Market)
Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐




Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On February 28, 2024, Mr. William Seeger notified the board of directors (the “Board”) of ICU Medical, Inc. (the “Company”) that he will retire from the board of directors of Smiths Group plc (“Smiths”) on May 31, 2024 and, in anticipation of his retirement, tendered his resignation from the Company Board and a member of the Audit and Compliance Committee of the Company Board as Smiths’ nominated director, effective immediately. Mr. Seeger’s resignation did not result from any disagreement with the Company or any matter relating to the Company’s operations, policies or practices.

Smiths Group retains the right to designate a board member as long as Smiths Group beneficially owns at least 5% of the outstanding shares of common stock of the Company as more fully described in the Shareholders Agreement dated January 6, 2022 between the Company and Smiths Group.



SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
    ICU MEDICAL, INC.
Date: February 29, 2024  By: /s/ Brian M. Bonnell
   Brian M. Bonnell
   Chief Financial Officer and Treasurer


 EX-101.SCH 2 icui-20240228.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 icui-20240228_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Entity Central Index Key Entity Central Index Key Amendment Flag Amendment Flag Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 icui-20240228_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Cover Page
Feb. 28, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Feb. 28, 2024
Entity Registrant Name ICU MEDICAL INC/DE
Entity Incorporation, State or Country Code DE
Entity File Number 001-34634
Entity Tax Identification Number 33-0022692
Entity Address, Address Line One 951 Calle Amanecer
Entity Address, City or Town San Clemente
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92673
City Area Code 949
Local Phone Number 366-2183
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock, par value $0.10 per share
Trading Symbol ICUI
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Amendment Flag false
Entity Central Index Key 0000883984
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 22 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.icumed.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports icui-20240228.htm icui-20240228.xsd icui-20240228_lab.xml icui-20240228_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "icui-20240228.htm": { "nsprefix": "icui", "nsuri": "http://www.icumed.com/20240228", "dts": { "inline": { "local": [ "icui-20240228.htm" ] }, "schema": { "local": [ "icui-20240228.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "icui-20240228_lab.xml" ] }, "presentationLink": { "local": [ "icui-20240228_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 23, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.icumed.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "icui-20240228.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "icui-20240228.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.icumed.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0000883984-24-000007-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000883984-24-000007-xbrl.zip M4$L#!!0 ( !%$75@:R+@["P\ .%R 1 :6-U:2TR,#(T,#(R."YH M=&WM7>MOVS@2_]Z_@O!>KPD0V98L/Y-XD3INU](4N[@O!UJB8UYE44M1 M<7Q__8 M[PB7^]?'[T[ZG5[OW>_M-TXS_YZ?_FYD%1W&9_5UW5#YA2OQ4T)"N ;JU*8M:NR&[YKLZ0D]<.A MD&.J8+SX>=DH6X9II8W@1WS=^,HXOE!1WV%)_86:DXJN9S:;S=(M$CPW,@-& MO5 YI>)[@S.K1KEA5,S9X*#JM_5=8FE:=:7F(AE8/* AF[4<\JQVH:Y9^NOL M<]\9L3$U%HAO>12FN,!\XVN_T#X:,>JVC\9,48+M&.SOB-\<%SK"5\Q7QM4T M@,^<^.FXH-BM*FD6E=IOWKPY4EQYK,V=B!LP)W;9LAI'I?CE42EN>B#<:?O( MY3G;9\X3,8 +]M844FXY_<=9FO?T+Y>31FDCMQ_[?JD@V/ M"XX!?/7I&%MBO'4R9KX+_ZD/'KTN$.X>%X8PED)[2+V0'946&MJ@W:X/9$PO MV34/<7[5.93,FC<+[5[G*SGKGO8Z)Y])[[Q3.NT^M*\.$"&IU_-==ON)36>= M685V&?X:C4JS8:]T4EIDFF1#)D&169@QUR@]K5#+! R#:,%K*9CAXT+(QX&' M J+?C22.A"Y.N^[OK).DS%)'43UH-6PFIF@ D-7W/-)WI$W?Q>ESVDEI@>Z423.NE.9DO 2:$*L#LVN MF\[ =6K_0>[=?9.HT)C[QHCQZY%JV5:Q7@W4X82[:M0RR^6W!5VU?10&%&1B M(''2XM]Q.RNMX9@-ZO%KO^4 $YDLQ!^GY8[PA&S]5M9_AT,@TAC2,?>FK7=7 M? R2=LXFY%*,J?_N( 0H!,R4?!A7#/G_6,MLP #UXR0>=!W:0?A,B3 M'/;7 M\]Y5]Y3TKTZNNOW%,>_@:/O=SM?+WE6OVRD^U?GCY/SCUW2N3@[Z_7[ MO8OS)R2AG(N$/T_Z?_3./UY=G!^0TV*G2*QRU6YN/.PL(7M4:JU^X^$4.B1@R+(LD5AXZ[M\X(C"4C M)X["8K-9L9__9-J9W$$;AC1>LD!(1?;29T;!BK%0$78#PR-2%S-W/R7H*6:2 M;*ZF7[15[L:VND!BSQQL[:UJN?#&&$,3(\.E4V,*%,_\+' SK)+5P. BP\UZ M;I)0R\7=.2_V -W8X@L L&R9W^O>4M!LE!84=3ES[ D-21@P!YU)EW"?2M=QH5)( MZP34Q0Q,RPINB9DE5\N",(;0SV./;V7C.&/#"+?G.T*"3=%YDKX"+.Z("(+> M:4>XBT"-:1<,S!0+I+C!=IB? G4%#!CSZ(3*U? ^55?E_HC#9>1O,GV_W$1\ MX!Z#R@,VLWXV!MFF4;%KE?7&[Y6KW^7J%;WM)6D)1XOX(HNKA7:E8I3+EE5K M6M_E<39P5,KW PZ/#5?L1VPZ"EDF;<[HY#!RCVS*];SL:>@@0A(!3KPD_P4? M/G2Y]O)_9+!WGSIP3O@\3NXON60O5PO7S'9'C,<\Q'4*@KA%8JW:?Q14>GFZ MT[OLD^XX\,24R>>O+(MX2\Y%,5-=-*"6M&^=,T1Y7.>]TJS%[N2FSGNYO$T/ M>9N-U;<\LOK6?/=:?8N-;75DIFG]N+7M1A42OUZ+<,_!ZSIQ78VF$_*P(.'4?1B)*(#/R_DE9C,(L=Z MH=V'X7<\AFG"AT2/N^8Z_11)R')^GE5 E@B"#A!9$ST= HM $Z M.-3V.7T-BA\T!U\$,-G[-P_B5$_,X";@LU6K5^X1#)OVBKTSJSO/TC4^><(C MS$L'$D24!]0C[)8YD>(WF*X&!Y>%CQ/Q[")_0&P(RLW^JF!LY-3OY')%]L+, M7GX]0SMW(AF=URRS#*J%2_F+BK6_P6K:9P'3_V4D_*5,H6D6VI5:S;#,QHKB M;KYZ]-C+0'<;NMZ%1#&/!4@A\36)!YAY\2)4#4*!H\ >E[W4!;'STLG.CW'O M UAJ)I-5.ZD--SS2&"]ANH8D7K6'8 E-._%HF*Y;/Z.UNZII%JOW"?^W&7M6 MMABOV\T<87&V8;=6#7MSQYW5;*O5&3'GF]YE0@/P+<&P8])Z(&[)@'EB@K*+ MA2CAI&%\(D/N(>[P$$!(,=\%F58"Q'H<>0HB5Q&%WI2$5/%P.-5?)A^( = : MI[^272US:]L1M /ZXD_3LB'(KIC@=^CO@P'T%,C SIA;N2VO6 M;?MPN]'HSJE#PB4@8YY-))C;J'49 >;:5C61VJ4-6K@O:\^LD\Z'2V)5RD6H MF.$/O@IN?L'M"X\[P%S_^@R@"0>15VHKOXK4WK&(C!,>K8JL:5-0Y#FI7=A+ M.)-9NUR,:[Z*[8/$]HMDB+5X_D!ORD5;*2^&0PQ1\HFO_:N(+[#*<.9X]4/T M-6W7L/8&^_F$.:[[*L[;%.=>&$9,WD.HJZ]"O4ZH*\RP]YQ\0IW4?:Q4$_=Q M!5N?.=DV.YNY0NPY#RN.&YB$R"/(VC^O@2&)(X!OK><38#>M8J-2>[L^OGZ; M%:E6[&+-;F06@:!DOE_7E-DL-FQ[*TW95M$J?W]4"0:_C.7,*SQ-&I].<$;$ M\6@8OK@EVRM)==*Q/QT/A/?BR#M/-MWK&60I] *D3$8PQUMN*?ZE>TQVQ/]C=5WQO.Z/E_3NX<[]DLR,97= MU#>+3]PO.[\('XO+]&8# !1BE1ZOD^\K&G1OE^QYZVN71BV=OXN$6F7K MOJ>>*JLJE6^_QLZ%GSW?Q5"3D<&4.'J-!\3V&[@R3!]&6%J X2&!(4*+3W$VO%S-.*M\=T2Y0O;P,'O]4&?$T\I< M'V ,\ CKIK&0; U,*RK! ;W XXZEP6K$< @]H? 1CTA5@3H.'CW%RG@WEDNE&\9+XNZZ]%=EC\[2 M7_.H620S%7\2?9SIQU(V[CLW *WW[')E+I>N'@I$/!U MS);O/J$#<* CM?K)C^XOVO0>I?KL'J61O%/&:V8,)*/?##H$L]:BWH1.0U3? MGW;9$F*= 8(LJ:-:830&+9BF88.!$-"JVBDN),EAHVH_@E:OI&Y,"[5:L3&I M%L'Q(_!WR@(J521U-N>42U -(4/4L [@%@6OY4+O597A(>EZB>+,5STD)T$@ MN*]TXAY*5K]# \'\D$+U*3F1$M4,:X=9U3<0^EGA(P*C9N&%3SZP@8Q@HHG5 M."!XO\@!.9-%\B?W/$[' #'L&G>Y"15?0H$(,Q 24BR.V/S'K[_YV\-RRH? MOL=B_=L\U*BD;_)@B+'> >GY3G&A>F)U9Q^H$06D90"4G@?HJ* /,I1BO*YK M>.B/ 51# E8\"DC@.>@DZK;C@KNQ^!!(3DG%C"D%&'8/M'<+:(L[FU.90'UA[@@!/,7UYV-*R&":-JQ74+)F.'&S=FJ1.1RI4NP+O 6]P3J M\Z-*,9;66FHG)'<4F/5#F ;0>(KF)Z7_@+#A$*7YAA$^'@.7H=B;%C>$_7O> M9I4M51L;G:W*-$IO++4)UQ:GS.6Q[89WD:?B&42.0]1/KR6+E^VTD9Z?#Q'O M5 .O$+"8Q,8$[#/8X+E:L_X$6/YXQ>^ !'J;!M-(%""RXG[YXG, AP6M G4 M< MCCP@K(>UNPE<&TAYK9B+S(+B>P)W*X:)N#I@/421Z.1[P= +M@:Y[#'?& M5M^F.B BI?T>[0!AVE?KN#.7(E[6%NAF+! F(FP71N5(/HA#51U28B,CX8$. M0X ZFV17*]*_J*_AKZ8QP8(AJ@EC_F+[H+7S=!1_DH#G5*^?+A\_'D?U&8SC M!7J*>'9B)US%73F+TN]]/#^Y^GK977^\8RX"U0+UL_8,Q=VD!6?NA% H$.C4#MKVE_1-^E!-P-&$*^A0,17B0W8B'I##'NQ(;T% M):DP G<'8E 1-TL[>SML(K5VJZ-"1<0:KLV)JMHV5:>/3#+RQ#-[>6D7U*U^^\8 MVD9^.A_F+U_+O"X;MH!>3Y9S?Z7IE:8EFNY]CNU)-PFL7!&;9^DOSVTTF1A5 M>ZQJSP'QNY4/0+SU(I+)'W M$%+ZY*Q(W@O?9YZ7A?^OROA*^BOINT)37@A^5>Q7Z7XE_>4I=F?$V9!\F&UV M2G9+Z"6V*\EH&,FYRW]?S&:@4OQ/#>I_G[#]?U!+ P04 " 11%U8&#/* MTW " !W!P $0 &EC=6DM,C R-# R,C@N>'-DS55=3]LP%'WOK_#R/.>K MH;01+=) 2).Z#3'0>)N<^":U2.W,=FCY][/=6"5 QRKM87VI<^\YYW[XWN3L M?+MNT"-(Q02?!TD8!PAX*2CC]3RXN[W"T^!\,1J=?<#X_M/-$EV*LEL#U^A" M M% T8;I%=(K0#^$?&"/!%TW1%="KC%>.-J%:)\DJU<:I7&:>9CWRGR2%D43XN,8)J5 MLV)R8E32V(EN5:[*%:P),J5QE6_5/%AIW>91M-ELPLTX%+*.TCA.HOLOR^\. M&O38AO&' 7I;R,;CQY%U%T2!A[.R8P,XL\VA82G6D2TV3M-I@(C6DA6=ABO3 ME4NH2-?H>=#Q7QUI6,6 FI8W8)LZ #QS:R)KT%_)&E1+2G@WY&*$D.T#6[=" M:L3?)/:-2&:S6;2UE05HU[>E*(EVXW"P$0Z/[1$G*1XGX5;1(/JKL$,AQI4F MO(1C8ILG['G_(H?]K1Z7@^<=GX,34U"&M7B,*#![<^.WPZM#<'O ]C",23@7 MVO&MI;>U+>.5V!F,R2:>^^QOH/*+\FKZWQ@1]Y<364K1O#-/42M%"U(S4,\W MQPFL)%3SP.X/]E/[LY40FDP\Y%6 X158MXD RNR-JW>Y+\A+Z*?62"AS#PWL M6O0_U]^0XMCZ#06:(PNWQ%OC1XS.@PMAWOW7I#:)6?O=S>=#+Q<7;P_WFEZ5 M0L4X0H M $M> 5 :6-U:2TR,#(T,#(R.%]L86(N>&ULU5Q=;]LX%GWOK^!Z7W:! M82U2I"06;0;=3+LH-M,&38H9[&)A\#,1:DN!K#3)OU]*MA,KEFQ*BE7MB^/8 M5Y?G'NO3;Y4<837X]>?7J M[5\@_/,?7\_ ;ZF\7>@D!Z>9YKE6X"[.KT%^K<$?:?8]_L'!^9SG)LT6$)Z4 MEYVF-P]9?'6= ^QALC';O)N]"8A E! /*A4:2#@A, H0@EQCP8CVO4!%OUR] MP5K@0"H*0X\I2 R.8"0(AXI()@)JO6"O=#J/D^]OB@?!EQK8\))E^>^[R76> MW[R93N_N[E[?BVS^.LVNIMCS_.G&>K(VO]^QO_-+:\08FY;O/IHNXSI#ZQ9- M__S][$)>ZP6'<;+,>2*+ 9;QFV7YXEDJ>5ZR?A 7:+0H_H,;,UB\!!&&/GI] MOU23DU< K.C(TKG^J@TH_G[[^JEQ2#8M+*:)OBH^VW.=Q:FZR'F6GW&AYQ9] MZ2U_N-'O)LMX<3/7F]>N,VWJWO'!FGZV'*1SM2:;E..O4O055W^3>RSF=+Q M[$++VRS.'S[7.G/?*%GPG 9<8ELP6($$ENI($?&A[X*)0DU8EH'L_SQ MGI[I!'Z[V Q?CK%_@$F+R/(&A69ZF=YF\JFV+>9U!L+ M+,IB(K "?K+!"#8@08'R[?0IG@XDSH].S7Q4K*2R@F1>3 /2['GHJ3P8^I.L MEA9U&?=2R]=7Z8^IO=3&C_WB"2R>E&IJ=#C=^=C>9QN4/),'.%Y;3&5J9S@W M.:S0;;)TX19.GKI]XBO:[* 3D&9*9W;66A- [7V'L+B,\[F>F4 A3+" !E-I M)Y-1"'D@,"1VSDD10J$4M*UP-\[')MH2%$@-0/AOXN]@ [>]:A_9Z-O9-JZST.)MV] 6WK=[]A>Q$7RQGS\^LTT9]O%T)G,\K],$1"P" R MH56ME)!'2D-/*XDU5THAYJK?Y\[')MT2'R@!@A5"=]GN$'=8L7WH.+)86S#1 M2JA-(7?2Z(ZSP>39%,:V,AMMVHOR,N/%2N[%PT*D\QFE'$D3:4B19I#(D-IV ME3/H&TI#6U4-\9T56?$\-CFNP8$5.G)GGV<)HJ/<-:F!!' M!&(6V"FM\GT8111#18GV&1?,4.4J18?QQB;0%610P?P+*%%;FL$:.2B@NZO7 MA??#FGYA-H^L])<@LE4::$%/I^3@XG^PE-$BV.U$TN:RKNGEO5+V/EJ6?K]D MYUGZ([;AS#A%&!.&H>;8EGC++&32QS!25&(/J8 )YQ*_;Z"1)I0UV"T%; "W M32,-_+KFC_ZL#9,X.A#6(5WL9Z-'GFAP/'""V!_>;F8X8-\^)9QGNNCCM?52 MG,WXM%S>ZNRRV-;*OAAC6TJ! P]Y1!2KW)&=^6L,F1=B&%(<(!IZ-FSGC:I# M@XTM-5B\4&X!!BO$8 49E)C=L\-!J@]GB)0%"5 H&C6\?"$,,BC!0T*?,3B!"$Q'/ M.5O4CC"V%/%XJ&V%$EB8H,#IGA;JB3R<"WK3<^0$T)J95J+?&WTGI==['$S> M>P/:UO1^P_9"/DU_Z.R]6.89E_F,H8 @A3$4)+ "%B: W(0>#%7(C$^8YER[ M"KCB>6S"+<&!_VS@_===L%7"#@NU,PU'%J@S ZV$61MM)T%6/0TFQ-H M@58 M;]"U&_^PT-E5G%S],TOO\FM;K6]X\C +=<@I"0P4@8\@X8C:9IP$D/H81T2A MP#?.=73/.&,3Y;JUW& %*[!@C;9M(UY/K6L?WINP8=KPMEQUZ,'W,M&C!:_W M.W 'OC>XW09\OWGO_GN['3121I&TRO<,-;84(P&%L"D!>;[!6(DH8,ZG6)J' M&5L*V.D;7Z39[M5F_Y\TV$?OK(_44X^AFV[71[],!WV1SF,9YS:9_&YG\%G, MY[,PPD0IA2&-? 5)B&W[K&0 F4$R8F'H4\]Y;V_7_=BD_H00;""V.%JZR]YA M8??CY,B";D-'NZ.EC5%W.URZZVZXXZ6-H50.F#9;=>B/BV7W3/-R$U@&FFF_ M^+*A9!XDNCC]K1"!'@Z%P,03THN:XKKW>^Y0GZ?+G,__'=^LSKWXVJ-^8!MA M(FU+'"(%([_8C0H5D52&GL=QI_WIRC!C$^+SS=856=CKB4LNL:T?=-7MS]F1K@VM<3^ZWKK[IM*EO71&A0D"1@D4%-M:B[G5 M.@]]*#T1^*%]1[*P[5Y2X7AL$G_<*"G M=\W*KERWRYJR\!0NT1[@^^T-;0= M::\=H=+1X!M!V_#K]G\J[W>MM*?64<;GGVP_>_\O_3##$BDEI2IFM7:22_T0 M,L\^&&PBRIC/ N*\YE0[PMC$MRX::Y2@A DLSK:%]3F1KC6U!SW#E%-W9CK4 MT8;H>Y30YQX'KIX- >T6SB;#]D)^;Y.!*A+"QSF_FOE>$&"*,23V\X4D,':^ M;#2!/BY_ZD;Z1!)7 5<\CTVXC^! @GZ,YYMOWD6^BH3'# QTP"$AQ5<6B4\@EH8JX]O>U7/^ M68#GSLI+=IG>)3.LF:&>YT$=!L).:D4 !:<44A-$))#(!-+Y3%/#&".5 MZ.-:2+FBF6:@P-IQS6B+T)8+1MUH&GBUR(FA[DM%NQST7R?:\OES%HEV@VI< M(:HQ[2KP2W[_2=D2'IOU;P^L*XD7&DJ)$) 1%$#"F>U=2:0A$U2$(98$:>?U MHKTCC53L%BVHPNU8G9L(=I7]"] VC/C;,]8A 1Q@HT<::/(\<#(X$.!N2CAT M0<_*O_YS%B<:S?R0(A2&'O0U#R%!2D/N,P:19('MBWU*J?.&;>,H(TT(C[5M M_0048,&7I.NN4878EG. KG0-/ MP9JK[3*".B?YS@8K7GS,;J NL<3Y0:]Q5 M^%_U55PB5>_/7[RZG]02P,$% @ $41=6-\9C8OKL;+40&S48Q;X]J=MF.RRL#D6'@GORUSL=E?5OW[N2]EO?KQ=5[-/ MF#9E4Q_.Z3Z9S[#V32CKU>'\MXMWH.<_'NWMO?D7P!__^7 V^ZGQUVNLV]E) M0MMBF-V4[>6LO<39[TWZJ_QD9^>5;6.3U@!'_64GS=5=*E>7[8P1)K;-MF?3 M@1*.2B$(A%!$$%8(T(I2L,B<$ LAU=O^K^'\\NVO3I8+&YN;O9O7:KVF[1:,$+X8MMZ M_M#\]DG[&]ZWIL:817_V[Z:;\KF&N5NZ^..7LX_^$M<6RGK3VMIW!C;EP:8_ M>-9XV_:J_U^_9M]LT?V#;3/H#@%EP.G^[2;,C_9FLWLY4E/A!XRS[ONW#Z>/ M3)9=0L.^;]:+[O3BI,DXG-M5YVQ_<7MWA8?S3;F^JOX^=IDP'L[SI25T626, MZ<[D#Y\O7GRV?I5PDY'IHSW+!Q[ZZ*R]Q!.\;;$.>!_?UD;5^$>-JD[=)FVO MK*S#JC^Z#%@N^YZ/W:9-UK=+-$7DLO# $ 4($PDX:3E$:0)15C&._G'@G=.; M['6?C WZ_57S:9$[SDEAO/O1J<)[19Z8NU?F97YO[[Z+W'9)HO1.: _6JGQ' M$.X@^TJ!N*"9R?>4LFZ4VU]:>^SUEQD]3G[6I( I#Q];[.9SGJB"EA.+O/RC>#ZR-K\Z"*?N/)\UUW::[DR;@4FIG"9<4E"4, MA.0:G-8.N",Z+ZVL0$%W ,8_.C&($S%U3G:G\R2P>5=6^.OUVF%:^CP!8G#9 M=^=M1EY3,,X&H,$:8XV4A1XWD7QM<1 0AJQ5&A ^B XS'<" MQQAEIT3(>;-I;?5G>=4OFX/QSG(J(/INMX4T1V$*!2)R8;UBCL@=3B>/; \K M9I'O!(^7R_K*<'2#WG%">^^W*(A5DD!0,GLKB@B.!0=2$!:%R6MIIT;A\*6U M80!,N)SY8NE>.>7=0X_J_+*IM]LGC=)[R018FP_C'"0\@"DXAQT2! M1R691RN%T:,8>-;L,! F7,,<+^8KT_"QJ4I?MF6]^B4O<%)IJR5C/C!6"*": M61!!6G >.9 0A'1YX!L6$ZY0[DG5:<)QN M-M>8OHPE2F(ST:3;!5$0%!%T01$L4T@$1Y-CW24B3SP8!LJ$"Y<[E?BU)Q3T MUWE2O*/,791MA4L59(PJ4^Z=RZ)0)4!')-"5U:0WVF@V;@3YVN(P'"91&[ZM[?^TM8K[!_E%]+DY6]VF&KO03"F0#N:(U'!*6:Y4F1<\?$Y MJ\,8F'#5<;24DZ@VOEUC6F64_YN:F_8R3VY7MKY;1I+S%ZP!:[3*V%?FXSBO<$*WRGE7V=4R(L]CG-802,B; M)&5C'N,< Y<'.6U8P7@<5W9X9&X8 Q,N.;Y?&5V& 43KCZ.%W-G-+Q9/!'Q+!\X MVGLXT7UTK\4?[?T/4$L! A0#% @ $41=6!K(N#L+#P X7( !$ M ( ! &EC=6DM,C R-# R,C@N:'1M4$L! A0#% @ $41= M6!@SRM-P @ =P< !$ ( !.@\ &EC=6DM,C R-# R,C@N M>'-D4$L! A0#% @ $41=6*/0\)!Y"@ 2UX !4 ( ! MV1$ &EC=6DM,C R-# R,CA?;&%B+GAM;%!+ 0(4 Q0 ( !%$75C?&8W, MJ08 .8P 5 " 84< !I8W5I+3(P,C0P,C(X7W!R92YX 8;6Q02P4& 0 ! $ 0 82, end XML 16 icui-20240228_htm.xml IDEA: XBRL DOCUMENT 0000883984 2024-02-28 2024-02-28 false ICU MEDICAL INC/DE 0000883984 8-K 2024-02-28 DE 001-34634 33-0022692 951 Calle Amanecer San Clemente CA 92673 949 366-2183 false false false false Common stock, par value $0.10 per share ICUI NASDAQ false